BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34733781)

  • 1. CT-Based Peritumoral and Intratumoral Radiomics as Pretreatment Predictors of Atypical Responses to Immune Checkpoint Inhibitor Across Tumor Types: A Preliminary Multicenter Study.
    He S; Feng Y; Lin Q; Wang L; Wei L; Tong J; Zhang Y; Liu Y; Ye Z; Guo Y; Yu T; Luo Y
    Front Oncol; 2021; 11():729371. PubMed ID: 34733781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI.
    Cheng Y; Xu S; Wang H; Wang X; Niu S; Luo Y; Zhao N
    Front Oncol; 2022; 12():1047572. PubMed ID: 36578933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.
    Li Y; Wang P; Xu J; Shi X; Yin T; Teng F
    Oncoimmunology; 2024; 13(1):2312628. PubMed ID: 38343749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer.
    Wu Y; Jiang W; Fu L; Ren M; Ai H; Wang X
    Abdom Radiol (NY); 2023 Feb; 48(2):733-743. PubMed ID: 36445408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
    Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
    Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from Breast DCE-MRI for Prediction of HER-2 and Ki-67 Status.
    Li C; Song L; Yin J
    J Magn Reson Imaging; 2021 Sep; 54(3):703-714. PubMed ID: 33955619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.
    Gabryś HS; Basler L; Burgermeister S; Hogan S; Ahmadsei M; Pavic M; Bogowicz M; Vuong D; Tanadini-Lang S; Förster R; Kudura K; Huellner M; Dummer R; Levesque MP; Guckenberger M
    Front Oncol; 2022; 12():977822. PubMed ID: 36505821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
    Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
    Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
    Li L; Wang L; Zeng F; Peng G; Ke Z; Liu H; Zha Y
    Eur Radiol; 2021 Oct; 31(10):7901-7912. PubMed ID: 33786655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Through CT-Based Tumoral and Peritumoral Radiomics.
    Ma Y; Guan Z; Liang H; Cao H
    Front Oncol; 2022; 12():831112. PubMed ID: 35237524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC.
    Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W
    Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
    Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
    Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
    Park C; Jeong DY; Choi Y; Oh YJ; Kim J; Ryu J; Paeng K; Lee SH; Ock CY; Lee HY
    Front Immunol; 2022; 13():1038089. PubMed ID: 36660547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
    Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
    Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of potential severe coronavirus disease 2019 patients based on CT radiomics: A retrospective study.
    Xiao F; Sun R; Sun W; Xu D; Lan L; Li H; Liu H; Xu H
    Med Phys; 2022 Sep; 49(9):5886-5898. PubMed ID: 35837868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of osteoporosis using radiomics analysis derived from single source dual energy CT.
    Wang J; Zhou S; Chen S; He Y; Gao H; Yan L; Hu X; Li P; Shen H; Luo M; You T; Li J; Zhong Z; Zhang K
    BMC Musculoskelet Disord; 2023 Feb; 24(1):100. PubMed ID: 36750927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients.
    Yang J; Shi W; Yang Z; Yu H; Wang M; Wei Y; Wen J; Zheng W; Zhang P; Zhao W; Chen L
    Transl Lung Cancer Res; 2023 Apr; 12(4):808-823. PubMed ID: 37197623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.